##gff-version 3
P51450	UniProtKB	Chain	1	516	.	.	.	ID=PRO_0000053518;Note=Nuclear receptor ROR-gamma	
P51450	UniProtKB	Domain	267	506	.	.	.	Note=NR LBD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01189	
P51450	UniProtKB	DNA binding	31	96	.	.	.	Note=Nuclear receptor;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00407	
P51450	UniProtKB	Zinc finger	31	51	.	.	.	Note=NR C4-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00407	
P51450	UniProtKB	Zinc finger	67	91	.	.	.	Note=NR C4-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00407	
P51450	UniProtKB	Region	1	30	.	.	.	Note=Modulating;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51450	UniProtKB	Region	104	145	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
P51450	UniProtKB	Motif	499	504	.	.	.	Note=AF-2	
P51450	UniProtKB	Compositional bias	117	134	.	.	.	Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
P51450	UniProtKB	Alternative sequence	1	24	.	.	.	ID=VSP_056787;Note=In isoform 3. MDRAPQRHHRTSRELLAAKKTHTS->MAGSYLHCA;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Alternative sequence	1	21	.	.	.	ID=VSP_003659;Note=In isoform 2. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:10602018,ECO:0000303|PubMed:9881970;Dbxref=PMID:10602018,PMID:9881970	
P51450	UniProtKB	Alternative sequence	22	24	.	.	.	ID=VSP_003660;Note=In isoform 2. HTS->MRT;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:10602018,ECO:0000303|PubMed:9881970;Dbxref=PMID:10602018,PMID:9881970	
P51450	UniProtKB	Alternative sequence	310	463	.	.	.	ID=VSP_056788;Note=In isoform 3. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Loss of adipogenesis inhibition%2C when associated with A-48. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21853531;Dbxref=PMID:21853531	
P51450	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Loss of adipogenesis inhibition%2C when associated with A-31. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21853531;Dbxref=PMID:21853531	
P51450	UniProtKB	Mutagenesis	56	57	.	.	.	Note=Abolishes DNA-binding. No effect neither on interaction with NCOA1 and NCOA2 nor on inhibition of NFATC1 expression. RR->AG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16148126;Dbxref=PMID:16148126	
P51450	UniProtKB	Mutagenesis	500	500	.	.	.	Note=Abolishes interaction with NCOA1 and NCOA2. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16148126;Dbxref=PMID:16148126	
P51450	UniProtKB	Mutagenesis	502	502	.	.	.	Note=Loss of transactivation function. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22753030;Dbxref=PMID:22753030	
P51450	UniProtKB	Sequence conflict	70	71	.	.	.	Note=QQ->HR;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Sequence conflict	142	142	.	.	.	Note=A->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Sequence conflict	181	181	.	.	.	Note=G->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Sequence conflict	181	181	.	.	.	Note=G->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Sequence conflict	186	186	.	.	.	Note=N->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Sequence conflict	207	207	.	.	.	Note=G->C;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51450	UniProtKB	Sequence conflict	352	352	.	.	.	Note=T->K;Ontology_term=ECO:0000305;evidence=ECO:0000305